Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Hua-Jay J. Cherng"'
Publikováno v:
Manual of Hematopoietic Cell Transplantation and Cellular Therapies ISBN: 9780323798334
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e153279b3d6382fd2a020e63f1eb4d7a
https://doi.org/10.1016/b978-0-323-79833-4.00009-7
https://doi.org/10.1016/b978-0-323-79833-4.00009-7
Autor:
Zaid Abdel Rahman, Syed Ali Abutalib, Aimaz Afrough, Sairah Ahmed, Taha Al-Juhaishi, Amin M Alousi, Leonard C. Alsfeld, Farrukh T. Awan, Ahsan Azhar, Qaiser Bashir, Brandon Douglas Brown, Kai Cao, Richard E. Champlin, Hua-Jay J. Cherng, Stefan O. Ciurea, Bouthaina Dabaja, May Daher, Marcos De Lima, Christen M. Dillard, Penny Fang, Marcelo A. Fernández Viña, Christopher James Ferreri, Fateeha Furqan, Nico Gagelmann, Praveen Ramakrishnan Geethakumari, Sassine Ghanem, Uri Greenbaum, Alison M. Gulbis, Ali Haider, Mehdi Hamadani, Victoria Wehr Handy, Misha C. Hawkins, Ella J. Ariza Heredia, Chitra Hosing, Jin Seon Im, Nitin Jain, Andrew P Jallouk, Mika L. Jankowski, Brandon J. Kale, Partow Kebriaei, Lana Khalil, Irum Khan, Sajad Khazal, Piyanuch Kongtim, Paul Lin, Kris M. Mahadeo, Alexandre E Malek, Kara McGee, Rohtesh S. Mehta, Victor Eduardo Mulanovich, Pashna N. Munshi, Loretta J. Nastoupil, Sattva S Neelapu, Yago Nieto, Amanda Olson, Betul Oran, Folashade Otegbeye, Akshat Maneesh Patel, Krina Patel, Prince Paul, Naveen Pemmaraju, Uday R Popat, Muzaffar H. Qazilbash, Hind Rafei, Dristhi S Ragoonanan, Jeremy L. Ramdial, Katayoun Rezvani, Ana Avila Rodriguez, Gabriela Rondón, Supawee Saengboon, Gabriela Sanchez-Petitto, Terri Lynn Shigle, Elizabeth J. Shpall, Samer A. Srour, Raphael E. Steiner, Karen R. Stolar, Paolo Strati, Nicholas A. Szewczyk, Mark R. Tanner, Kevin Tang, Peter F. Thall, Sudhakar Tummala, Chukwuemeka Uzoka, Whitney D. Wallis, Jason R. Westin, Nathaniel R. Wilson, Susan Wu, Eduardo Yepez Guevara, Jun Zou
Publikováno v:
Manual of Hematopoietic Cell Transplantation and Cellular Therapies ISBN: 9780323798334
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd4108048a50ce283e308d026c579bfa
https://doi.org/10.1016/b978-0-323-79833-4.00042-5
https://doi.org/10.1016/b978-0-323-79833-4.00042-5
Autor:
Hua‐Jay J. Cherng, Guofan Xu, Lei Feng, Raphael Steiner, Luis Fayad, Paolo Strati, Ranjit Nair, Loretta J. Nastoupil, Hun Ju Lee, Sattva S. Neelapu, Christopher R. Flowers, Maria Rodriguez, Michael Wang, Fredrick Hagemeister, Chelsea C. Pinnix, Jeremy Ramdial, Samer Srour, Yago Nieto, Katayoun Rezvani, Richard Champlin, Partow Kebriaei, Jason Westin, Homer A. Macapinlac, Elizabeth Shpall, Sairah Ahmed
Publikováno v:
British Journal of Haematology. 200:35-44
Salvage chemotherapy followed by high-dose chemotherapy and autologous stem cell transplantation (ASCT) is a potentially curative treatment for patients with relapsed or refractory large B-cell lymphoma (rrLBCL) with chemosensitive disease. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cc3a2f0e340856ad0d00934140b2d10
https://doi.org/10.1111/bjh.18441
https://doi.org/10.1111/bjh.18441
Autor:
Hua-Jay J. Cherng, Ryan Sun, Bryant Sugg, Russell Irwin, Haopeng Yang, Cao Cuong Le, Qing Deng, Luis Fayad, Nathan H. Fowler, Simrit Parmar, Raphael Steiner, Fredrick Hagemeister, Ranjit Nair, Hun Ju Lee, Maria Rodriguez, Felipe Samaniego, Swaminathan P. Iyer, Christopher R. Flowers, Linghua Wang, Loretta J. Nastoupil, Sattva S. Neelapu, Sairah Ahmed, Paolo Strati, Michael R. Green, Jason Westin
Publikováno v:
Blood. 140:504-515
Patients with relapsed or refractory large B-cell lymphomas (rrLBCL) can achieve long-term remission after CD19 chimeric antigen receptor T-cell therapy (CART19). However, more than half of recipients will experience treatment failure. Thus, approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9911912d2c35d7d55a44638dfed2abbb
https://doi.org/10.1182/blood.2022015601
https://doi.org/10.1182/blood.2022015601
Autor:
Hua‐Jay J. Cherng, Raamis Khwaja, Rashmi Kanagal‐Shamanna, Guilin Tang, Jan Burger, Philip Thompson, Alessandra Ferrajoli, Zeev Estrov, Koji Sasaki, Deepa Sampath, Xuemei Wang, Hagop Kantarjian, Michael Keating, William G. Wierda, Nitin Jain
Publikováno v:
American Journal of Hematology. 97:1005-1012
Long-term follow up of prospective studies has shown that continuous Bruton's tyrosine kinase inhibitor (BTKi) therapy leads to durable remissions in previously untreated patients with TP53-altered chronic lymphocytic leukemia (CLL); however, it is u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2fbbce11598a73b9457cfb664bd6bff
https://doi.org/10.1002/ajh.26595
https://doi.org/10.1002/ajh.26595
Autor:
Hua-Jay J. Cherng, Stefan K. Alig, Yasuhiro Oki, Loretta J. Nastoupil, Luis Fayad, Sattva S. Neelapu, Francesco Turturro, Fredrick Hagemeister, Alexander F. M. Craig, Charles W. Macaulay, Maria Alma Rodriguez, Hun Ju Lee, Timothy J. McDonnell, Christopher R. Flowers, Francisco Vega, Michael R. Green, Lei Feng, David M. Kurtz, Ash A. Alizadeh, R. Eric Davis, Jason R. Westin
Publikováno v:
Blood advances.
Diffuse large B-cell lymphoma (DLBCL) can be cured with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP); however, one-third of patients experience refractory or relapsed disease. Studies comparing R-CHOP with modified r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e477c03ad5c43cee912a3fa7c2e42031
https://pubmed.ncbi.nlm.nih.gov/36375046
https://pubmed.ncbi.nlm.nih.gov/36375046
Autor:
Hua-Jay J. Cherng, Nitin Jain
Publikováno v:
Hematology/Oncology Clinics of North America. 35:725-738
Novel therapies largely have replaced chemoimmunotherapy as optimal first-line treatment of chronic lymphocytic leukemia (CLL). Approved novel therapies for CLL in the first-line setting include Bruton tyrosine kinase inhibitors, ibrutinib and acalab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cdfc58b1215100faeb6f4a06da11c29
https://doi.org/10.1016/j.hoc.2021.03.005
https://doi.org/10.1016/j.hoc.2021.03.005
Autor:
Hua-Jay J. Cherng, Jason R. Westin
Publikováno v:
Clin Cancer Res
In RE-MIND2 (NCT04697160), patient-level outcomes from the L-MIND study (NCT02399085) of tafasitamab plus lenalidomide were retrospectively compared with patient-level matched observational cohorts treated with National Cancer Care Network (NCCN)/Eur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8623a526e2e839253eb5ea8ef454c3a
https://europepmc.org/articles/PMC9481674/
https://europepmc.org/articles/PMC9481674/
Autor:
Philip A. Thompson, Susan O'Brien, Zeev Estrov, Shilpa Paul, Koji Sasaki, Hua Jay J. Cherng, Xuemei Wang, Jan A. Burger, Nadya Jammal, Michael J. Keating, Alessandra Ferrajoli, William G. Wierda, Nitin Jain
Publikováno v:
Br J Haematol
Chronic lymphocytic leukaemia (CLL) rarely presents in adolescent and young adult (AYA) patients (patients aged 15-39 years). Disease characteristics and outcomes of AYA patients with CLL are not well understood, particularly in the era of novel oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6eeda1763bdc5686b16031e09bc79b9
https://doi.org/10.1111/bjh.17498
https://doi.org/10.1111/bjh.17498
Autor:
Jan Boegeholz, Stefan K. Alig, Brian Sworder, Joseph Schroers-Martin, Charles Macaulay, Alexander F.M. Craig, Ulrich Duehrsen, Andreas Hüttmann, Jason Westin, Hua-Jay J. Cherng, David B. Miklos, Matthew J Frank, Maximilian Diehn, David M. Kurtz, Ash A. Alizadeh
Publikováno v:
Blood. 140:8609-8610
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d1a7bdbb3cf41d68e04683a35534985
https://doi.org/10.1182/blood-2022-170087
https://doi.org/10.1182/blood-2022-170087